| 000 | 01798 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514060138.0 | ||
| 264 | 0 | _c20030410 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0767-3981 | ||
| 024 | 7 |
_a10.1046/j.1472-8206.2002.00077.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiebolt, Myriam | |
| 245 | 0 | 0 |
_aWine polyphenols modulate calcium handling in rat aorta: involvement of nitric oxide pathway. _h[electronic resource] |
| 260 |
_bFundamental & clinical pharmacology _cAug 2002 |
||
| 300 |
_a289-96 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCyclic GMP-Dependent Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aPhenols _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aThapsigargin _xpharmacology |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 | _aWine |
| 700 | 1 | _aAndriantsitohaina, Ramaroson | |
| 773 | 0 |
_tFundamental & clinical pharmacology _gvol. 16 _gno. 4 _gp. 289-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1472-8206.2002.00077.x _zAvailable from publisher's website |
| 999 |
_c12368146 _d12368146 |
||